Merigolix
N/A
Report date: 2026/03/31 20:00:21
NME
Base Information
Drug NameMerigolix
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTiumBio Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesHansoh Pharmaceutical Group Company LtdJiangsu Hansoh Pharmaceutical Group Co LtdDaewon Pharmaceutical Co Ltd +[5]
Inactive CompaniesSk Chemicals Co Ltd
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A